Genetic predisposition to neural crest-derived ...
Document type :
Compte-rendu et recension critique d'ouvrage
DOI :
PMID :
Permalink :
Title :
Genetic predisposition to neural crest-derived tumors: revisiting the role of KIF1B
Author(s) :
Cardot Bauters, Catherine [Auteur]
Hôpital Claude Huriez [Lille]
Leteurtre, Emmanuelle [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Carnaille, Bruno [Auteur]
Hôpital Claude Huriez [Lille]
Université de Lille
Do Cao, Christine [Auteur]
Service des Maladies de l'Appareil Digestif et de la Nutrition [CHRU Lille]
Espiard, Stéphanie [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Penven, Malo [Auteur]
Institut de Microbiologie [CHRU Lille]
Destailleur, Evelyne [Auteur]
Szuster, Isabelle [Auteur]
Lovecchio, Tonio [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Leclerc, Julie [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Site de recherche intégrée en cancérologie [SiRIC CURAMUS]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Frénois, Fredéric [Auteur]
Maladies RAres du DEveloppement embryonnaire et du MEtabolisme : du Phénotype au Génotype et à la Fonction - ULR 7364 [RADEME]
Esquivel, Emmanuel [Auteur]
Dahia, Patricia [Auteur]
Ait-Yahya, Emilie [Auteur]
Crépin, Michel [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Pigny, Pascal [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hôpital Claude Huriez [Lille]
Leteurtre, Emmanuelle [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Carnaille, Bruno [Auteur]
Hôpital Claude Huriez [Lille]
Université de Lille
Do Cao, Christine [Auteur]
Service des Maladies de l'Appareil Digestif et de la Nutrition [CHRU Lille]
Espiard, Stéphanie [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Penven, Malo [Auteur]
Institut de Microbiologie [CHRU Lille]
Destailleur, Evelyne [Auteur]
Szuster, Isabelle [Auteur]
Lovecchio, Tonio [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Leclerc, Julie [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Site de recherche intégrée en cancérologie [SiRIC CURAMUS]
Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 [CANTHER]
Frénois, Fredéric [Auteur]
Maladies RAres du DEveloppement embryonnaire et du MEtabolisme : du Phénotype au Génotype et à la Fonction - ULR 7364 [RADEME]
Esquivel, Emmanuel [Auteur]
Dahia, Patricia [Auteur]
Ait-Yahya, Emilie [Auteur]
Crépin, Michel [Auteur]
Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 [JPArc]
Pigny, Pascal [Auteur]
Lille Neurosciences & Cognition - U 1172 [LilNCog]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Journal title :
Endocrine Connections
Pages :
1042-1050
Publisher :
BioScientifica Ltd.
Publication date :
2020-10
English keyword(s) :
neural crest
pheochromocytoma
genetic predisposition
endocrine tumor
pheochromocytoma
genetic predisposition
endocrine tumor
HAL domain(s) :
Sciences du Vivant [q-bio]/Cancer
English abstract : [en]
Objective We previously described a family in which predisposition to pheochromocytoma (PCC) segregates with a germline heterozygous KIF1B nucleotide variant (c.4442G>A, p.Ser1481Asn) in three generations. During the ...
Show more >Objective We previously described a family in which predisposition to pheochromocytoma (PCC) segregates with a germline heterozygous KIF1B nucleotide variant (c.4442G>A, p.Ser1481Asn) in three generations. During the clinical follow-up, one proband’s brother, negative for the KIF1B nucleotide variant, developed a bilateral PCC at 31 years. This prompted us to reconsider the genetic analysis. Design and methods Germline DNA was analyzed by next-generation sequencing (NGS) using a multi-gene panel plus MLPA or by whole exome sequencing (WES). Tumor-derived DNA was analyzed by SnapShot, Sanger sequencing or NGS to identify loss-of-heterozygosity (LOH) or additional somatic mutations. Results A germline heterozygous variant of unknown significance in MAX (c.145T>C, p.Ser49Pro) was identified in the proband’s brother. Loss of the wild-type MAX allele occurred in his PCCs thus demonstrating that this variant was responsible for the bilateral PCC in this patient. The proband and her affected grandfather also carried the MAX variant but no second hit could be found at the somatic level. No other pathogenic mutations were detected in 36 genes predisposing to familial PCC/PGL or familial cancers by WES of the proband germline. Germline variants detected in other genes, TFAP2E and TMEM214 , may contribute to the multiple tumors of the proband. Conclusion In this family, the heritability of PCC is linked to the MAX germline variant and not to the KIF1B germline variant which, however, may have contributed to the occurrence of neuroblastoma (NB) in the proband.Show less >
Show more >Objective We previously described a family in which predisposition to pheochromocytoma (PCC) segregates with a germline heterozygous KIF1B nucleotide variant (c.4442G>A, p.Ser1481Asn) in three generations. During the clinical follow-up, one proband’s brother, negative for the KIF1B nucleotide variant, developed a bilateral PCC at 31 years. This prompted us to reconsider the genetic analysis. Design and methods Germline DNA was analyzed by next-generation sequencing (NGS) using a multi-gene panel plus MLPA or by whole exome sequencing (WES). Tumor-derived DNA was analyzed by SnapShot, Sanger sequencing or NGS to identify loss-of-heterozygosity (LOH) or additional somatic mutations. Results A germline heterozygous variant of unknown significance in MAX (c.145T>C, p.Ser49Pro) was identified in the proband’s brother. Loss of the wild-type MAX allele occurred in his PCCs thus demonstrating that this variant was responsible for the bilateral PCC in this patient. The proband and her affected grandfather also carried the MAX variant but no second hit could be found at the somatic level. No other pathogenic mutations were detected in 36 genes predisposing to familial PCC/PGL or familial cancers by WES of the proband germline. Germline variants detected in other genes, TFAP2E and TMEM214 , may contribute to the multiple tumors of the proband. Conclusion In this family, the heritability of PCC is linked to the MAX germline variant and not to the KIF1B germline variant which, however, may have contributed to the occurrence of neuroblastoma (NB) in the proband.Show less >
Language :
Anglais
Popular science :
Non
Source :
Submission date :
2024-04-12T09:11:35Z
Files
- EC-20-0460.pdf
- Open access
- Access the document